Abstract
Background: Pancreatic Cancer (PaC) is estimated to be the 2nd leading cause of death by 2030 because of its late diagnosis. Screening entire populations would be economically impractical. This results in a need to pinpoint high-risk populations. A liquid biopsy can be performed on these populations to identify repeatable predictive biomarkers.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
